MONDELEZ INTERNATIONAL INC-A (MDLZ) Fundamental Analysis & Valuation

NASDAQ:MDLZUS6092071058

Current stock price

57.51 USD
-0.87 (-1.49%)
At close:
58.15 USD
+0.64 (+1.11%)
After Hours:

This MDLZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. MDLZ Profitability Analysis

1.1 Basic Checks

  • MDLZ had positive earnings in the past year.
  • MDLZ had a positive operating cash flow in the past year.
  • In the past 5 years MDLZ has always been profitable.
  • MDLZ had a positive operating cash flow in each of the past 5 years.
MDLZ Yearly Net Income VS EBIT VS OCF VS FCFMDLZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • MDLZ's Return On Assets of 3.43% is fine compared to the rest of the industry. MDLZ outperforms 65.12% of its industry peers.
  • MDLZ has a better Return On Equity (9.49%) than 74.42% of its industry peers.
  • MDLZ's Return On Invested Capital of 5.26% is fine compared to the rest of the industry. MDLZ outperforms 61.63% of its industry peers.
  • MDLZ had an Average Return On Invested Capital over the past 3 years of 7.90%. This is in line with the industry average of 6.80%.
Industry RankSector Rank
ROA 3.43%
ROE 9.49%
ROIC 5.26%
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)14.7%
ROE(5y)13.89%
ROIC(3y)7.9%
ROIC(5y)7.13%
MDLZ Yearly ROA, ROE, ROICMDLZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • MDLZ's Profit Margin of 6.36% is amongst the best of the industry. MDLZ outperforms 80.23% of its industry peers.
  • MDLZ's Profit Margin has declined in the last couple of years.
  • MDLZ's Operating Margin of 9.48% is fine compared to the rest of the industry. MDLZ outperforms 75.58% of its industry peers.
  • In the last couple of years the Operating Margin of MDLZ has declined.
  • The Gross Margin of MDLZ (28.38%) is better than 66.28% of its industry peers.
  • In the last couple of years the Gross Margin of MDLZ has declined.
Industry RankSector Rank
OM 9.48%
PM (TTM) 6.36%
GM 28.38%
OM growth 3Y-8.01%
OM growth 5Y-9.55%
PM growth 3Y-9.66%
PM growth 5Y-13.81%
GM growth 3Y-7.55%
GM growth 5Y-6.31%
MDLZ Yearly Profit, Operating, Gross MarginsMDLZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

3

2. MDLZ Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MDLZ is creating some value.
  • MDLZ has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for MDLZ has been reduced compared to 5 years ago.
  • Compared to 1 year ago, MDLZ has a worse debt to assets ratio.
MDLZ Yearly Shares OutstandingMDLZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
MDLZ Yearly Total Debt VS Total AssetsMDLZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 2.25 indicates that MDLZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • MDLZ has a better Altman-Z score (2.25) than 61.63% of its industry peers.
  • The Debt to FCF ratio of MDLZ is 6.55, which is on the high side as it means it would take MDLZ, 6.55 years of fcf income to pay off all of its debts.
  • MDLZ's Debt to FCF ratio of 6.55 is fine compared to the rest of the industry. MDLZ outperforms 68.60% of its industry peers.
  • MDLZ has a Debt/Equity ratio of 0.77. This is a neutral value indicating MDLZ is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.77, MDLZ perfoms like the industry average, outperforming 40.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 6.55
Altman-Z 2.25
ROIC/WACC0.7
WACC7.56%
MDLZ Yearly LT Debt VS Equity VS FCFMDLZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • MDLZ has a Current Ratio of 0.59. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.59, MDLZ is doing worse than 84.88% of the companies in the same industry.
  • A Quick Ratio of 0.39 indicates that MDLZ may have some problems paying its short term obligations.
  • MDLZ's Quick ratio of 0.39 is on the low side compared to the rest of the industry. MDLZ is outperformed by 81.40% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.39
MDLZ Yearly Current Assets VS Current LiabilitesMDLZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

4

3. MDLZ Growth Analysis

3.1 Past

  • The earnings per share for MDLZ have decreased strongly by -15.36% in the last year.
  • The Earnings Per Share has been growing slightly by 2.19% on average over the past years.
  • The Revenue has been growing slightly by 5.75% in the past year.
  • MDLZ shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.71% yearly.
EPS 1Y (TTM)-15.36%
EPS 3Y-0.68%
EPS 5Y2.19%
EPS Q2Q%10.77%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y6.96%
Revenue growth 5Y7.71%
Sales Q2Q%9.29%

3.2 Future

  • Based on estimates for the next years, MDLZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.76% on average per year.
  • MDLZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.25% yearly.
EPS Next Y6.12%
EPS Next 2Y8.63%
EPS Next 3Y8.1%
EPS Next 5Y8.76%
Revenue Next Year3.42%
Revenue Next 2Y3.27%
Revenue Next 3Y3.21%
Revenue Next 5Y3.25%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MDLZ Yearly Revenue VS EstimatesMDLZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
MDLZ Yearly EPS VS EstimatesMDLZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

3

4. MDLZ Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 19.70, MDLZ is valued on the expensive side.
  • MDLZ's Price/Earnings ratio is in line with the industry average.
  • MDLZ's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.21.
  • A Price/Forward Earnings ratio of 18.56 indicates a rather expensive valuation of MDLZ.
  • MDLZ's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 23.10. MDLZ is around the same levels.
Industry RankSector Rank
PE 19.7
Fwd PE 18.56
MDLZ Price Earnings VS Forward Price EarningsMDLZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as MDLZ.
  • 61.63% of the companies in the same industry are more expensive than MDLZ, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 22.79
EV/EBITDA 18.2
MDLZ Per share dataMDLZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MDLZ does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of MDLZ may justify a higher PE ratio.
PEG (NY)3.22
PEG (5Y)8.99
EPS Next 2Y8.63%
EPS Next 3Y8.1%

6

5. MDLZ Dividend Analysis

5.1 Amount

  • MDLZ has a Yearly Dividend Yield of 3.43%.
  • Compared to an average industry Dividend Yield of 2.26, MDLZ pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, MDLZ pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.43%

5.2 History

  • The dividend of MDLZ is nicely growing with an annual growth rate of 10.23%!
  • MDLZ has paid a dividend for at least 10 years, which is a reliable track record.
  • MDLZ has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.23%
Div Incr Years12
Div Non Decr Years12
MDLZ Yearly Dividends per shareMDLZ Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • MDLZ pays out 101.47% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of MDLZ is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP101.47%
EPS Next 2Y8.63%
EPS Next 3Y8.1%
MDLZ Yearly Income VS Free CF VS DividendMDLZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
MDLZ Dividend Payout.MDLZ Dividend Payout, showing the Payout Ratio.MDLZ Dividend Payout.PayoutRetained Earnings

MDLZ Fundamentals: All Metrics, Ratios and Statistics

MONDELEZ INTERNATIONAL INC-A

NASDAQ:MDLZ (4/7/2026, 8:50:10 PM)

After market: 58.15 +0.64 (+1.11%)

57.51

-0.87 (-1.49%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-03
Earnings (Next)04-28
Inst Owners88.72%
Inst Owner Change0%
Ins Owners0.18%
Ins Owner Change5.01%
Market Cap73.72B
Revenue(TTM)38.54B
Net Income(TTM)2.45B
Analysts77.06
Price Target68.24 (18.66%)
Short Float %2.53%
Short Ratio2.89
Dividend
Industry RankSector Rank
Dividend Yield 3.43%
Yearly Dividend1.91
Dividend Growth(5Y)10.23%
DP101.47%
Div Incr Years12
Div Non Decr Years12
Ex-Date03-31
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.76%
Min EPS beat(2)0.24%
Max EPS beat(2)1.28%
EPS beat(4)4
Avg EPS beat(4)4.31%
Min EPS beat(4)0.24%
Max EPS beat(4)10.18%
EPS beat(8)7
Avg EPS beat(8)5.06%
EPS beat(12)11
Avg EPS beat(12)5.53%
EPS beat(16)15
Avg EPS beat(16)5.46%
Revenue beat(2)0
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-0.15%
Revenue beat(4)0
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-2.09%
Max Revenue beat(4)-0.15%
Revenue beat(8)0
Avg Revenue beat(8)-1.43%
Revenue beat(12)3
Avg Revenue beat(12)-0.47%
Revenue beat(16)7
Avg Revenue beat(16)0.45%
PT rev (1m)0.36%
PT rev (3m)-1.89%
EPS NQ rev (1m)-0.18%
EPS NQ rev (3m)-23.37%
EPS NY rev (1m)-3.08%
EPS NY rev (3m)-3.38%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-1.79%
Revenue NY rev (1m)-0.28%
Revenue NY rev (3m)-0.51%
Valuation
Industry RankSector Rank
PE 19.7
Fwd PE 18.56
P/S 1.91
P/FCF 22.79
P/OCF 16.33
P/B 2.85
P/tB N/A
EV/EBITDA 18.2
EPS(TTM)2.92
EY5.08%
EPS(NY)3.1
Fwd EY5.39%
FCF(TTM)2.52
FCFY4.39%
OCF(TTM)3.52
OCFY6.12%
SpS30.06
BVpS20.16
TBVpS-14.14
PEG (NY)3.22
PEG (5Y)8.99
Graham Number36.39
Profitability
Industry RankSector Rank
ROA 3.43%
ROE 9.49%
ROCE 7.36%
ROIC 5.26%
ROICexc 5.48%
ROICexgc 44.22%
OM 9.48%
PM (TTM) 6.36%
GM 28.38%
FCFM 8.39%
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)14.7%
ROE(5y)13.89%
ROIC(3y)7.9%
ROIC(5y)7.13%
ROICexc(3y)8.16%
ROICexc(5y)7.43%
ROICexgc(3y)63.45%
ROICexgc(5y)50.76%
ROCE(3y)10.65%
ROCE(5y)9.63%
ROICexgc growth 3Y21.26%
ROICexgc growth 5Y4.14%
ROICexc growth 3Y1.32%
ROICexc growth 5Y-3.02%
OM growth 3Y-8.01%
OM growth 5Y-9.55%
PM growth 3Y-9.66%
PM growth 5Y-13.81%
GM growth 3Y-7.55%
GM growth 5Y-6.31%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 6.55
Debt/EBITDA 3.97
Cap/Depr 94.18%
Cap/Sales 3.32%
Interest Coverage 6.41
Cash Conversion 90.06%
Profit Quality 131.99%
Current Ratio 0.59
Quick Ratio 0.39
Altman-Z 2.25
F-Score5
WACC7.56%
ROIC/WACC0.7
Cap/Depr(3y)97.41%
Cap/Depr(5y)92.16%
Cap/Sales(3y)3.4%
Cap/Sales(5y)3.29%
Profit Quality(3y)93.68%
Profit Quality(5y)93.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.36%
EPS 3Y-0.68%
EPS 5Y2.19%
EPS Q2Q%10.77%
EPS Next Y6.12%
EPS Next 2Y8.63%
EPS Next 3Y8.1%
EPS Next 5Y8.76%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y6.96%
Revenue growth 5Y7.71%
Sales Q2Q%9.29%
Revenue Next Year3.42%
Revenue Next 2Y3.27%
Revenue Next 3Y3.21%
Revenue Next 5Y3.25%
EBIT growth 1Y-45.43%
EBIT growth 3Y-1.61%
EBIT growth 5Y-2.57%
EBIT Next Year34.33%
EBIT Next 3Y15.04%
EBIT Next 5Y13.29%
FCF growth 1Y-8.17%
FCF growth 3Y2.52%
FCF growth 5Y0.85%
OCF growth 1Y-8.07%
OCF growth 3Y4.92%
OCF growth 5Y2.63%

MONDELEZ INTERNATIONAL INC-A / MDLZ Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?

ChartMill assigns a fundamental rating of 4 / 10 to MDLZ.


Can you provide the valuation status for MONDELEZ INTERNATIONAL INC-A?

ChartMill assigns a valuation rating of 3 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Overvalued.


How profitable is MONDELEZ INTERNATIONAL INC-A (MDLZ) stock?

MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 6 / 10.


How financially healthy is MONDELEZ INTERNATIONAL INC-A?

The financial health rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 3 / 10.


How sustainable is the dividend of MONDELEZ INTERNATIONAL INC-A (MDLZ) stock?

The dividend rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 6 / 10 and the dividend payout ratio is 101.47%.